Clarius Group LLC trimmed its holdings in shares of Becton, Dickinson and Firm (NYSE:BDX – Free Report) by 15.8% within the third quarter, in response to the corporate in its most up-to-date Type 13F submitting with the Securities and Alternate Fee. The fund owned 1,390 shares of the medical devices provider’s inventory after promoting 261 shares in the course of the quarter. Clarius Group LLC’s holdings in Becton, Dickinson and Firm have been value $334,000 on the finish of the latest reporting interval.
A number of different institutional traders and hedge funds have additionally made modifications to their positions in BDX. Virtu Monetary LLC purchased a brand new stake in shares of Becton, Dickinson and Firm in the course of the fourth quarter value $1,646,000. Syon Capital LLC lifted its place in shares of Becton, Dickinson and Firm by 10.8% in the course of the fourth quarter. Syon Capital LLC now owns 1,468 shares of the medical devices provider’s inventory value $358,000 after buying an extra 143 shares over the last quarter. Scarborough Advisors LLC purchased a brand new stake in shares of Becton, Dickinson and Firm in the course of the fourth quarter value $32,000. Northwest Financial institution & Belief Co purchased a brand new stake in shares of Becton, Dickinson and Firm in the course of the fourth quarter value $151,000. Lastly, Willner & Heller LLC purchased a brand new stake in shares of Becton, Dickinson and Firm in the course of the fourth quarter value $291,000. 86.97% of the inventory is at the moment owned by institutional traders.
Analyst Scores Adjustments
A number of analysis corporations lately weighed in on BDX. Raymond James decreased their worth goal on Becton, Dickinson and Firm from $275.00 to $270.00 and set an “outperform” score for the corporate in a report on Friday, August 2nd. StockNews.com upgraded Becton, Dickinson and Firm from a “maintain” score to a “purchase” score in a report on Thursday, August eighth. Citigroup upgraded Becton, Dickinson and Firm from a “impartial” score to a “purchase” score and lifted their worth goal for the corporate from $255.00 to $275.00 in a report on Tuesday, October 1st. Evercore ISI lifted their worth goal on Becton, Dickinson and Firm from $286.00 to $290.00 and gave the corporate an “outperform” score in a report on Tuesday, October 1st. Lastly, Stifel Nicolaus lifted their goal worth on Becton, Dickinson and Firm from $270.00 to $280.00 and gave the corporate a “purchase” score in a analysis observe on Friday, July twenty sixth. 9 analysis analysts have rated the inventory with a purchase score, In line with information from MarketBeat, the corporate at the moment has a consensus score of “Purchase” and a consensus worth goal of $282.63.
View Our Newest Evaluation on BDX
Becton, Dickinson and Firm Value Efficiency
Shares of BDX inventory opened at $236.50 on Friday. Becton, Dickinson and Firm has a fifty-two week low of $218.75 and a fifty-two week excessive of $262.55. The agency has a market capitalization of $68.35 billion, a price-to-earnings ratio of 52.09, a PEG ratio of 1.79 and a beta of 0.42. The corporate has a debt-to-equity ratio of 0.70, a fast ratio of 1.36 and a present ratio of 1.85. The inventory’s 50-day easy transferring common is $236.37 and its 200-day easy transferring common is $235.38.
Becton, Dickinson and Firm (NYSE:BDX – Get Free Report) final issued its quarterly earnings outcomes on Thursday, August 1st. The medical devices provider reported $3.50 earnings per share for the quarter, topping analysts’ consensus estimates of $3.31 by $0.19. Becton, Dickinson and Firm had a return on fairness of 14.49% and a web margin of seven.13%. The enterprise had income of $4.99 billion for the quarter, in comparison with analyst estimates of $5.08 billion. Throughout the identical quarter within the earlier yr, the agency earned $2.96 earnings per share. The corporate’s income was up 2.3% on a year-over-year foundation. As a bunch, equities analysts forecast that Becton, Dickinson and Firm will submit 13.11 earnings per share for the present fiscal yr.
Becton, Dickinson and Firm Pronounces Dividend
The agency additionally lately declared a quarterly dividend, which was paid on Monday, September thirtieth. Stockholders of document on Monday, September ninth have been paid a dividend of $0.95 per share. The ex-dividend date of this dividend was Monday, September ninth. This represents a $3.80 dividend on an annualized foundation and a dividend yield of 1.61%. Becton, Dickinson and Firm’s payout ratio is 83.70%.
Becton, Dickinson and Firm Firm Profile
Becton, Dickinson and Firm develops, manufactures, and sells medical provides, gadgets, laboratory gear, and diagnostic merchandise for healthcare establishments, physicians, life science researchers, scientific laboratories, pharmaceutical business, and most people worldwide. The corporate operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.
Additional Studying
Obtain Information & Scores for Becton Dickinson and Firm Each day – Enter your e mail handle under to obtain a concise day by day abstract of the most recent information and analysts’ scores for Becton Dickinson and Firm and associated corporations with MarketBeat.com’s FREE day by day e mail e-newsletter.
